The following clinical trials for Arcus’s product candidates are currently enrolling patients:

AB122 – A Phase 1 Study to Evaluate the Safety and Tolerability of AB122 in Subjects with Advanced Solid Tumors

For more information on our clinical trials, please contact the following email address: ClinicalTrialInquiry@www.arcusbio.com